Mitchel Muhleman, MD
Associate Professor of Radiology
Radiology
1500 E. Medical Center Dr, B1G505 UH SPC 5028
Ann Arbor, MI 48109-5028
[email protected]

Available to mentor
Mitchel Muhleman, MD
Clinical Associate Professor
  • About
  • Qualifications
  • Research Overview
  • Recent Publications
    • About

    I have chosen the “clinician-research scholar” track, which I feel is the best fit for me. In my time as a practicing nuclear medicine attending, I have authored two Nuclear Medicine textbook chapters and two accepted peer reviewed journal articles. I was also co-author on two Radiology textbook chapters and five additional peer-reviewed journal articles. I am also currently involved in 8 other research projects, which include Co-investigator and sole positron emission tomography interpreter for the current study, Neuroinflammatory markers and the risk of Post-Traumatic Epilepsy with the use of F-18 TSPO PET/CT and EEs-FC analysis, where I have also been heavily involved in study design and parameters.

    Qualifications
    • MD
      St. George's University School of Medicine, Grenada, 2011
    • Diploma of Higher Education with Commendation in Medical Sciences
      University of Northumbria, Newcastle, 2008
    • BS
      Western Illinois University, Macomb, 2006
    • BA
      Western Illinois University, Macomb, 2006
    Research Overview

    Clinical application of neuronuclear radiotracers to improve evaluation and response to treatment of neurological disorders.

    Investigation of radiotracers ability to evaluate response to treatment of malignancy treated with radioactive targeted therapies.

    Recent Publications See All Publications
    • Journal Article
      One institutions' experience with a true standard 15 mCi dose of I-131 for the treatment of Graves' disease.
      Muhleman MA, Fahim A, Benefield T, Oldan JD, Khandani AH. Nucl Med Commun, 2023 Jan 1; 44 (1): 49 - 55. DOI:10.1097/MNM.0000000000001633
      PMID: 36514928
    • Presentation
      Amyloid and Sarcoidosis in Nuclear Cardiac Imaging
      Muhleman M. 2022 Oct 7;
    • Journal Article
      Qualitative and quantitative methods in post-chemoradiation PET for head and neck cancer.
      Oldan JD, Beaty BM, Jewells VL, Muhleman MA, Benefield T, Chera B. Nucl Med Commun, 2022 Jun 1; 43 (6): 710 - 716. DOI:10.1097/MNM.0000000000001558
      PMID: 35414636
    • Presentation
      Nuclear Cardiac Imaging.
      Muhleman M. 2021 Oct 8;
    • Chapter
      Huntington’s Disease
      Zamora C, Muhleman MA, Castillo M. 2021 Jan 1; Hybrid PET/MR Neuroimaging: A Comprehensive Approach, 411 - 419. DOI:10.1007/978-3-030-82367-2_35
    • Chapter
      Multiple System Atrophy
      Zamora C, Muhleman MA, Castillo M. 2021 Jan 1; Hybrid PET/MR Neuroimaging: A Comprehensive Approach, 361 - 372. DOI:10.1007/978-3-030-82367-2_31
    • Chapter
      PET/CT and PET/MR in soft tissue sarcoma and melanoma patients: What to image and how to image it
      Muhleman M, Ivanovic M, Khandani AH. 2020 Dec 11; PET/CT and PET/MR in Melanoma and Sarcoma, 31 - 77. DOI:10.1007/978-3-030-60429-5_3
    • Chapter
      Patient preparation for FDG PET with an emphasis on soft tissue sarcoma and melanoma: What matters (and what doesn't)
      Muhleman M, Khandani AH. 2020 Dec 11; PET/CT and PET/MR in Melanoma and Sarcoma, 9 - 29. DOI:10.1007/978-3-030-60429-5_2